By establishing that Kurdish NSCLC patients having a unique molecular subgroup, these findings highlight the significance of population-specific genomic profiling in precision oncology and cast doubt on long-held beliefs regarding the epidemiology of EGFR mutations in Asian populations. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.